OpenVSafe by OpenVAERS
Search V-safe

2AN-10051-84930

2 vaccinations 3 coded responses 8 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
176 / PA
Registered
2021-11-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-20
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-21
    Registered in v-safe
  3. 2021-11-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Nausea, Diarrhea
    Adult check-in
  4. 2021-11-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-11-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pregnancy — Feeling: Good
    Free text: 35 weeks pregnant
    MedDRA releases: 2024-11 · check-in free text available
  6. 2021-11-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pregnancy — Feeling: Good
    Free text: 35 weeks pregnant
    MedDRA releases: 2024-11 · check-in free text available
  7. 2021-11-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-12-11
    Dose 2 — Pfizer-BioNTech
  9. 2021-12-11
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  10. 2021-12-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  11. 2022-01-24
    Survey response — day 42, dose 2
    MedDRA: Increased viscosity of upper respiratory secretion, Secretion discharge — Feeling: Good
    Free text: Increased mucous and phlegm
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-11-20Pfizer-BioNTech No
22021-12-11Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 1

2021-11-23

Systemic reaction (other): 35 weeks pregnant

2021-11-24

Systemic reaction (other): 35 weeks pregnant

Release 11 — day 42, dose 2

2022-01-24

Symptoms: Increased mucous and phlegm

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDIncreased viscosity of upper respiratory secretion · · ✓
SDSecretion discharge · · ✓
SROPregnancy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release